PDS Biotechnology (PDSB)
(Delayed Data from NSDQ)
$1.13 USD
+0.01 (0.89%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.12 -0.01 (-0.88%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, PDS Biotechnology Corporation has a market cap of $51.19M, which represents its share price of $1.12 multiplied by its outstanding shares number of 45.71M. As a small-cap company, PDSB's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PDSB 1.13 +0.01(0.89%)
Will PDSB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PDSB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PDSB
Take the Zacks Approach to Beat the Markets: StoneCo, Axon, Intuit in Focus
Down -35.74% in 4 Weeks, Here's Why PDS Biotechnology (PDSB) Looks Ripe for a Turnaround
PDSB: What are Zacks experts saying now?
Zacks Private Portfolio Services
PDS Biotechnology (PDSB) Upgraded to Strong Buy: Here's What You Should Know
Best Momentum Stocks to Buy for October 15th
Other News for PDSB
12 Health Care Stocks Moving In Wednesday's After-Market Session
PDS Biotechnology (PDSB) Advances in Clinical Trial for Colorectal Cancer | PDSB Stock News
PDS Biotech completes patient recruitment in Stage 1 colorectal cancer trial
PDS Biotechnology (PDSB) Retains "Buy" Rating with Price Target Unchanged | PDSB ...
PDS Biotechnology Updates on HPV16 Cancer Trial Progress